Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma

British Journal of Haematology

Volumn 139, Issue 3, 2007, Pages 443-449

  Mann, Georg ^a   Attarbaschi, Andishe ^a   Burkhardt, Birgit ^b   Niggli, Felix ^c   Klapper, Wolfram ^d   Ludwig, Wolf Dieter ^e   Schrappe, Martin ^d   Zimmermann, Martin ^b   Gadner, Helmut ^a   Reiter, Alfred ^b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e Section of Pathology   (Germany)

Author keywords

Incidence; Infant; Mixed lineage leukaemia gene; Non Hodgkin lymphoma; Outcome

Indexed keywords

ANTINEOPLASTIC AGENT; MIXED LINEAGE LEUKEMIA PROTEIN;

ARTICLE; ATAXIA TELANGIECTASIA; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; INFANT; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME;

EUROPE; FEMALE; HUMANS; INFANT; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, ANAPLASTIC; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; NEOPLASM STAGING; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34848912224     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06796.x     Document Type: Article

References (28)

1. Attarbaschi, A., Mann, G., König, M., Steiner, M., Strehl, S., Schreiberhuber, A., Schneider, B., Meyer, C., Marschalek, R., Borkhardt, A., Pickl, W.F., Lion, T., Gadner, H., Haas, O.A. Dworzak, M.N. (2006) Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity. Clinical Cancer Research, 12, 2988 2994.
2. Biondi, A., Cimino, G., Pieters, R. Pui, C.H. (2000) Biological and therapeutic aspects of infant leukemia. Blood, 96, 24 33.
3. Burkhardt, B., Zimmermann, M., Oschlies, I., Niggli, F., Mann, G., Parwaresch, R., Riehm, H., Schrappe, M. Reiter, A. (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. British Journal of Haematology, 131, 39 49.
4. Burkhardt, B., Woessmann, W., Zimmermann, M., Kontny, U., Vormoor, J., Doerffel, W., Mann, G., Henze, G., Niggli, F., Ludwig, W.D., Janssen, D., Riehm, H., Schrappe, M. Reiter, A. (2006) Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma. Journal of Clinical Oncology, 24, 491 499.
5. Eguchi, M., Eguchi-Ishimae, M., Knight, D., Kearney, L., Slany, R. Greaves, M. (2006) MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia. Genes, Chromosomes and Cancer, 45, 754 760.
6. Ford, A.M., Ridge, S.A., Cabrera, M.E., Mahmoud, H., Steel, C.M., Chan, L.C. Greaves, M. (1993) In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature, 363, 358 360.
7. Gill Super, H.J., Rothberg, P.G., Kobayashi, H., Freeman, A.I., Diaz, M.O. Rowley, J.D. (1994) Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. Blood, 83, 641 644.
8. Goubin, A., Auclerc, M.F., Auvrignon, A., Patte, C., Bergeron, C., Hemon, D. Cavel, J. (2006) Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000). European Journal of Cancer, 42, 534 541.
9. Greaves, M.F. (1996) Infant leukaemia biology, aetiology and treatment. Leukemia, 10, 372 377.
10. Greaves, M.F. (2004) Biological models for leukaemia and lymphoma. IARC Scientific Publications 157, 351 372.
11. Grümayer, E.R., Ladenstein, R.L., Slavc, I., Urban, C., Radaszkiewicz, T., Bettelheim, P. Gadner, H. (1988) B-cell differentiation pattern of cutaneous lymphomas in infancy and childhood. Cancer, 61, 303 308.
12. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Müller-Hermelink, H.K., Vardiman, J., Lister, T.A. Bloomfield, C.D. (2000) The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997. The Hematology Journal, 1, 53 66.
13. Kumar, J., Seith, A., Bakhshi, S., Sharma, R. Kumar, A. (2007) Multifocal non-Hodgkin lymphoma in an infant with cardiac involvement: whole-body MR imaging. Pediatric Radiology, 37, 321 324.
14. Neth, O., Seidemann, K., Jansen, P., Mann, G., Tiemann, M., Ludwig, W.D., Riehm, H.J. Reiter, A. (2000) Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90. Medical and Pediatric Oncology, 35, 20 27.
15. Overberg-Schmidt, U., Wegner, R.D., Baumgarten, E., Gunther, A., Ebell, W., Stein, H., Vogel, M. Henze, G. (1994) Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia telangiectasia. Cancer, 73, 1522 1525.
16. Pui, C.H. (2006) Neonatal leukemia: a nemesis for pediatric oncologists Pediatric Blood & Cancer, 47, 234 235.
17. Pui, C.H., Kane, J.R. Crist, W.M. (1995) Biology and treatment of infant leukemias. Leukemia, 9, 762 769.
18. Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Müller- Weihrich, S., Sauter, S., Sykora, K.W., Ludwig, W.D., Gadner, H. Riehm, H. (1995) Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. Journal of Clinical Oncology, 13, 359 372.
19. Reiter, A., Schrappe, M., Tiemann, M., Ludwig, W.D., Yakisan, E., Zimmermann, M., Mann, G., Chott, A., Ebell, W., Klingebiel, T., Graf, N., Kremens, B., Müller-Weihrich, S., Plüss, H.J., Zintl, F., Henze, G. Riehm, H. (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 94, 3294 3306.
20. Reiter, A., Schrappe, M., Ludwig, W.D., Tiemann, M., Parwaresch, R., Zimmermann, M., Schirg, E., Henze, G., Schellong, G., Gadner, H. Riehm, H. (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood, 95, 416 421.
21. Sandlund, J.T., Downing, J.R. Crist, W.M. (1996) Non-Hodgkin's lymphoma in childhood. The New England Journal of Medicine, 334, 1238 1248.
22. Sebire, N.J, Webb, D. Ramsay, A.D. (2005) Anaplastic large cell lymphoma with ALK expression and presence of the t(2;5) translocation in a 5-month-old infant. Fetal and Pediatric Pathology, 24, 63 70.
23. Seidemann, K., Tiemann, M., Henze, G., Sauerbrey, A., Müller, S. Reiter, A. (1999) Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials. Medical and Pediatric Oncology, 33, 536 544.
24. Seidemann, K., Henze, G., Beck, J.D., Sauerbrey, A., Kühl, J., Mann, G. Reiter, A. (2000) Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Annals of Oncology, 11 (Suppl. 1 141 145.
25. Seidemann, K., Tiemann, M., Schrappe, M., Yakisan, E., Simonitsch, I., Janka-Schaub, G., Dörffel, W., Zimmermann, M., Mann, G., Gadner, H., Parwaresch, R., Riehm, H. Reiter, A. (2001) Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood, 97, 3699 3706.
26. Umebayashi, Y., Nameki, H., Saito, Y. Mori, N. (1990) Cutaneous malignant lymphoma in an infant. The Journal of Dermatology, 17, 755 759.
27. Varan, A., Gököz, A., Akyüz, C., Kutluk, T., Yalcin, B., Köksal, Y. Büyükpamukçu, M. (2005) Primary malignant skin tumors in children: etiology, treatment and prognosis. Pediatrics International, 47, 653 657.
28. Wössmann, W., Seidemann, K., Mann, G., Zimmermann, M., Burkhardt, B., Oschlies, I., Ludwig, W.D., Klingebiel, T., Graf, N., Gruhn, B., Juergens, H., Niggli, F., Parwaresch, R., Gadner, H., Riehm, H., Schrappe, M. Reiter, A. (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood, 105, 948 958.